Theranos, the blood-testing startup that many investigative pieces suggest is not very good at testing blood, is reportedly getting the Hollywood treatment.
Deadline reports that Jennifer Lawrence has signed onto the project, a drama that is being directed by “The Big Short” director Adam McKay. Lawrence is expected to portray 32-year-old Theranos CEO Elizabeth Holmes, who was once considered one of Silicon Valley’s rising stars.
Theranos last raised capital in a funding round that set the company's value at $9 billion. Forbes, which once put Holmes on its cover, has since revised down its appraisal of the company’s value to around $800 million. This would mean that Holmes, once a paper billionaire several times over, now has a net worth of about zero.
But back to the movie. Jennifer Lawrence’s last go at playing a female entrepreneur in “Joy” didn’t come off so well. The David O. Russell flick was pretty bad. But McKay is fresh off a deserved Oscar win for the critically acclaimed “Big Short,” which was a funny movie about last decade’s devastating financial collapse.
Next up: Will Nick Bilton’s 2013 book on Twitter's origin story finally get made into a movie?
This article originally appeared on Recode.net.